Compare · BLLN vs CI
BLLN vs CI
Side-by-side comparison of BillionToOne Inc. (BLLN) and The Cigna Group (CI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and CI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $73.81B, about 15.6x BLLN ($4.72B).
- BLLN has been more active in the news (9 items in the past 4 weeks vs 7 for CI).
- CI has more recent analyst coverage (25 ratings vs 8 for BLLN).
- Company
- BillionToOne Inc.
- The Cigna Group
- Price
- -
- -
- Market cap
- $4.72B
- $73.81B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 9
- 7
- Recent ratings
- 8
- 25
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest BLLN
- Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
- SVP of Laboratory Operations Ten Bosch John Roderick sold $131,583 worth of shares (1,417 units at $92.86) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 27,884 units (SEC Form 4)
- Chief Technology Officer Tsao David exercised 10,000 shares at a strike of $2.80 and sold $928,600 worth of shares (10,000 units at $92.86) as part of a pre-agreed trading plan (SEC Form 4)
- Chairman and CEO Atay Oguzhan exercised 15,539 shares at a strike of $2.80 and sold $2,331,352 worth of shares (15,539 units at $150.03) as part of a pre-agreed trading plan (SEC Form 4)
- Chairman and CEO Atay Oguzhan exercised 32,500 shares at a strike of $2.80 and sold $6,167,960 worth of shares (45,000 units at $137.07) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
- Chief Product Officer Sakakibara Shan Riku sold $560,840 worth of shares (4,000 units at $140.21) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 200,000 units (SEC Form 4)
- Officer Johnson Nancy Joann sold $1,821,628 worth of shares (14,199 units at $128.29) as part of a pre-agreed trading plan, decreasing direct ownership by 67% to 6,900 units (SEC Form 4)
Latest CI
- SEC Form 4 filed by Officer Holgerson Bryan
- Officer Jones Nicole S sold $748,516 worth of shares (2,677 units at $279.61) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 25,880 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- Officer Jones Nicole S exercised 15,346 shares at a strike of $192.02 and sold $5,369,584 worth of shares (19,436 units at $276.27) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 28,557 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- The Cigna Group downgraded by Jefferies with a new price target
- The Cigna Group downgraded by Raymond James with a new price target
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook